Fatal arrhythmia following ingestion of hawthorn root (Crataegus pubescens) extract: a case report
Open Access
- 22 July 2022
- journal article
- research article
- Published by The Korean Society of Emergency Medicine in Clinical and Experimental Emergency Medicine
- Vol. 9 (4) , 373-376
Abstract
The use of extracts from the hawthorn plant as cardiovascular agents dates back to the 1st century; recently, they have also been made available online as weight loss aids. Herein, we present a case of intentional intoxication with hawthorn root extract (HRE) in an adult patient that resulted in death. A 20-year-old female patient, who was clinically diagnosed with depression, developed hypotension, bradycardia, and depressed consciousness after ingestion of this extract. An electrocardiogram recorded a sinus arrest with a slow nodal rhythm, which rapidly deteriorated, leading to cardiac arrest. This case report illustrates the potentially fatal consequences of HRE for which the constituents have not yet been characterized. All physicians, especially those in the emergency department, should be aware of the dangerous, even potentially fatal interactions of HRE with prescription medications.Keywords
This publication has 12 references indexed in Scilit:
- Prevalence of the risk factors for QT prolongation and associated drug–drug interactions in a cohort of medical inpatientsJournal of the Formosan Medical Association, 2019
- Review of Complementary and Alternative Medical Treatment of ArrhythmiasThe American Journal of Cardiology, 2014
- Position paper update: gastric lavage for gastrointestinal decontaminationClinical Toxicology, 2013
- Composition and health effects of phenolic compounds in hawthorn (Crataegus spp.) of different originsJournal of the Science of Food and Agriculture, 2012
- Towards a Systematic Scientific Approach in the Assessment of Efficacy of An Herbal Preparation: Hawthorn ( Crataegus spp.)European Journal of Heart Failure, 2008
- Hawthorn extract for treating chronic heart failure2005
- Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1 , and KCNE2 in drug-induced long QT syndrome patientsJournal of Molecular Medicine, 2004
- Clinical Relevance and Management of Drug‐Related QT Interval ProlongationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- Survival and Prognosis: Investigation of Crataegus Extract WS 1442 in Congestive Heart Failure (SPICE) — Rationale, Study Design and Study ProtocolEuropean Journal of Heart Failure, 2000
- The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of CardiologyEuropean Heart Journal, 2000